Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. financial statements

Allogene Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 010-K
Net income−USD 190.89M10-K
Cash and equivalentsUSD 51.69M10-Q
Total debtUSD 83.25MEODHD

Allogene Therapeutics, Inc. financials on 6ix · Allogene Therapeutics, Inc. on 6ix